


Leveraging the ACR’s RISE Registry for Research

The Problem with Peer Review

The Half-Life of the Truth
Some Drug Trials Resume after Declines During Pandemic

More Money, More Research: Foundation Report Sheds Light on Funding Gaps
Influential Lancet Article on HCQ Retracted

Finding Opportunity Through Challenge: Q&A with Vaneet K. Sandhu, MD, FACR, RhMSUS
COVID-19 Pandemic Leads Big Drugmakers to Hit Pause on Clinical Trials

The Third Choice: The Predatory Journal Scam
- 1
- 2
- 3
- …
- 66
- Next Page »